Vaccine composition with aluminium hydroxide nanoparticles
US9770505B2 · kind B2 · utility
1Cited by
2References
18Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jul 12, 2012 |
| Grant date | Sep 26, 2017 |
| Priority date | — |
| Expiry date | Jun 10, 2033 |
Classification
- Technology area (CPC Y)Emerging Cross-Sectional Technologies
- CPC primaryY02A50/30
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
A vaccine composition comprising at least one antigen and one adjuvant, characterized in that the adjuvant comprises sterile-filterable nanoparticles comprising pseudo-boehmite and polyacrylate.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.